πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs
4,713

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Page 49 of 99

  1. IASO206 injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed/Refractory Multiple Myeloma (RRMM)

    phase 1 small molecule active

    1 trial

  2. IBR733 Cell Injection

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 1 mab active

    1 trial

  3. ICG-Cisplatin Nanoprobe (NIR-II NanoM)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cancer, Adult

    phase 1 small molecule active

    1 trial

  4. ICI201

    The First People's Hospital of Lianyungang

    Relapsed/Refractory Multiple Myeloma

    phase 1 small molecule terminated

    1 trial

  5. ICT-121 DC vaccine

    Chongqing Precision Biotech Co., Ltd

    Glioblastoma Multiforme

    phase 1 mab completed

    1 trial

  6. ID-LV305

    Lxo Ireland Designated Activity Company

    Melanoma - Currently Enrolling

    phase 1 mab completed

    1 trial

  7. IDC-G305

    Lxo Ireland Designated Activity Company

    Melanoma

    phase 1 mab completed

    1 trial

  8. IDE-161

    IDEAYA Biosciences

    Advanced or Metastatic Solid Tumors

    phase 1 small molecule active

    1 trial

  9. IDE034

    IDEAYA Biosciences

    Esophageal Squamous Cell Carcinoma

    phase 1 small molecule active

    1 trial

  10. IDE397

    IDEAYA Biosciences

    Solid Tumor

    phase 1 small molecule active

    1 trial

  11. IDE892

    IDEAYA Biosciences

    NSCLC Adenocarcinoma

    phase 1 small molecule active

    1 trial

  12. IFx-Hu2.0

    TuHURA Biosciences, Inc./NV

    Cutaneous Melanoma, Stage III

    phase 1 mab completed

    1 trial

  13. IFx-Hu2.0

    TuHURA Biosciences, Inc./NV

    Cutaneous Squamous Cell Carcinoma

    phase 1 mab completed

    1 trial

  14. IFx-Hu2.0

    TuHURA Biosciences, Inc./NV

    Merkel Cell Carcinoma

    phase 1 mab completed

    1 trial

  15. IL-2

    Alaunos Therapeutics

    Lymphoma

    phase 1 small molecule completed

    1 trial

  16. IL-22BP mRNA vaccine injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Refractory Malignant Solid Tumors

    phase 1 mab active

    1 trial

  17. IMC-I109V Single Ascending Dose

    Immunocore Ireland Limited

    Hepatitis B, Chronic

    phase 1 small molecule terminated

    1 trial

  18. IMM-BCP-01

    United Therapeutics Europe Ltd

    SARS-CoV2 Infection

    phase 1 small molecule terminated

    1 trial

  19. IMP3-saRNA (YMN-136) Vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-Small Cell Lung Cancer

    phase 1 mab active

    1 trial

  20. INAVAC (Vaksin Merah Putih - UA- SARS CoV-2 (Vero Cell Inactivated) 5 ΞΌg

    Hospital Authority, Hong Kong

    COVID-19 Pandemic

    phase 1 mab active

    1 trial

  21. INBRX-101/rhAAT-Fc

    Inhibrx Biosciences

    Alpha-1 Antitrypsin Deficiency

    phase 1 small molecule completed

    1 trial

  22. INBRX-105 - PDL1x41BB antibody

    Inhibrx Biosciences

    Metastatic Solid Tumors

    phase 1 small molecule terminated

    1 trial

  23. INBRX-109

    Inhibrx Biosciences

    Ewing Sarcoma

    phase 1 small molecule active

    1 trial

  24. INC280 single agent

    Novartis Pharmaceuticals

    Non-Small Cell Lung Cancer

    phase 1 small molecule terminated

    1 trial

  25. INCA33890

    Incyte

    Solid Tumors

    phase 1 small molecule active

    1 trial

  26. INCB099280

    Incyte

    Advanced Solid Tumor

    phase 1 small molecule completed

    1 trial

  27. INCB099280, YERVOY 5 mg/ml concentrate for solution for infusion, YERVOY 5 mg/ml concentrate for solution for infusion

    Incyte

    Solid tumor

    phase 1 small molecule active

    1 trial

  28. INDV-2000

    Indivior Pty Ltd

    Healthy

    phase 1 small molecule completed

    1 trial

  29. INDV-2000

    Indivior Pty Ltd

    Opioid Dependence

    phase 1 small molecule completed

    1 trial

  30. INDV-2000

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  31. INDV-6200

    Indivior Pty Ltd

    Opioid-use Disorder

    phase 1 small molecule completed

    1 trial

  32. INFS (Intranasal Fentanyl Spray)

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  33. INO-1400

    INOVIO PHARMACEUTICALS, INC.

    Breast Cancer

    phase 1 mab completed

    1 trial

  34. INO-1800

    INOVIO PHARMACEUTICALS, INC.

    Hepatitis B

    phase 1 mab completed

    1 trial

  35. INO-3106, INO-9012

    INOVIO PHARMACEUTICALS, INC.

    Aerodigestive Precancerous Lesions and Malignancies

    phase 1 mab completed

    1 trial

  36. INO-3401 + EP

    INOVIO PHARMACEUTICALS, INC.

    Healthy

    phase 1 mab completed

    1 trial

  37. INO-3605

    INOVIO PHARMACEUTICALS, INC.

    Healthy

    phase 1 mab completed

    1 trial

  38. INO-4201

    INOVIO PHARMACEUTICALS, INC.

    Ebola Virus Disease

    phase 1 mab completed

    1 trial

  39. INO-4201

    INOVIO PHARMACEUTICALS, INC.

    Ebola Vaccine

    phase 1 mab completed

    1 trial

  40. INO-4500

    INOVIO PHARMACEUTICALS, INC.

    Lassa Fever

    phase 1 small molecule completed

    2 trials

  41. INO-5401

    INOVIO PHARMACEUTICALS, INC.

    BRCA1/2 Mutation

    phase 1 small molecule active

    1 trial

  42. INO-A002

    INOVIO PHARMACEUTICALS, INC.

    Healthy Volunteers

    phase 1 mab completed

    1 trial

  43. INTERACT MESO: Intraperitoneal Paclitaxel for Patients with Primary Malignant Peritoneal Mesothelioma – a Phase I/II Dose Escalation and Safety Study

    Disc Medicine

    Patients with malignant peritoneal mesothelioma

    phase 1 other active

    1 trial

  44. INTERACT stomach

    Disc Medicine

    Stomach Cancer with metastasis in the peritoneum

    phase 1 other active

    1 trial

  45. INV21 Low Dose

    Takeda

    Hand, Foot and Mouth Disease

    phase 1 mab completed

    1 trial

  46. INXN-1001

    Alaunos Therapeutics

    Melanoma

    phase 1 small molecule completed

    1 trial

  47. INZ-701, INZ-701

    Lacuna Pharma Pty Ltd

    Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Deficiency or ATP-binding Cassette Sub-family C Member 6 (ABCC6) Deficiency

    phase 1 small molecule active

    1 trial

  48. IO-108

    BEONE MEDICINES AUS PTY LTD

    Solid Tumor, Adult

    phase 1 mab completed

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources Β· All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.